Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Immunoprecise Antibodies Ltd

(OTHER OTC: IPATF)
Add to Portfolio
+0.0505 (+12.05%)
as of 15:53 EDT

Last 0.4695
Change +0.0505 (+12.05%)
Open 0.4321
Prev. Close 0.4190
Today's Range
0.4276
0.4695
52wk Range
0.3821
0.7573
Volume 5,125
Avg Volume 16,106
Sector All Sectors By Industry

Perfomance Comparison

Name Today 3-Month 1-Year
IPATF +12.05% -7.78% -36.19%
DJIA -0.19% +0.87% +2.61%
S&P 500 unch +0.46% +3.40%

Key Statistics

Annual EPS N/A
Dividend Yield N/A
P/E Ratio N/A
Market Capitalization, $K N/A
Weighted Alpha -36.46
Standard Deviation +1.95
Profit Margin N/A
Beta N/A

Growth Rates

YTD -8.09%
1-Year -43.38%

Opinion

Sell Hold Buy

Recent Headlines

ImmunoPrecise Antibodies' Annual Revenues Increase

CNW Group via COMTEX - Wed Aug 28, 06:33PM EDT
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) today reports its financial results for the year ended April 30, 2019. The financial statements and related Management's Discussion and A(full story)
IPATF: 0.4695 (+0.0505), IPA.VN: 0.620 (+0.060)

ImmunoPrecise's Wholly Owned Talem Therapeutics

CNW Group via COMTEX - Thu Aug 01, 08:00AM EDT
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB PINK: IPATF) announces the launch of its High Value Target Scientific Committee which will strengthen the scientific oversight and methodological pra(full story)
IPATF: 0.4695 (+0.0505), IPA.VN: 0.620 (+0.060)

ImmunoPrecise Antibodies Announces Immuno-oncology

CNW Group via COMTEX - Mon Jul 15, 08:30AM EDT
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF), an industry leader in the discovery of novel, therapeutic monoclonal antibodies, announces that it has entered into a new antibody discov(full story)
IPATF: 0.4695 (+0.0505), IPA.VN: 0.620 (+0.060)

ImmunoPrecise Guarantees Success for Customers of

CNW Group via COMTEX - Wed Jun 26, 08:15AM EDT
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF), the industry leader in the discovery of novel, therapeutic monoclonal antibodies, announces that from this point forward it will guarante(full story)
IPATF: 0.4695 (+0.0505), IPA.VN: 0.620 (+0.060)

ImmunoPrecise Antibodies Announces an Unprecedented

CNW Group via COMTEX - Thu May 30, 08:30AM EDT
The Diversified Offerings of 9 Transgenic Animal Strains Platforms supports Solid Growth in Drug Discovery Services(full story)
IPATF: 0.4695 (+0.0505), IPA.VN: 0.620 (+0.060)